St. Jude Children's Research Hospital

  • Website:
  • Address: 262 Danny Thomas Place Memphis, TN 38105
  • Phone: 866-278-5833

St. Jude is a leading children's hospital internationally recognized for pioneering research and treatment of childhood cancer and other life-threatening diseases. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago.

Families never receive a bill from St. Jude for treatment, travel, housing or food — because all a family should worry about is helping their child live. ALSAC, the fundraising and awareness organization for St. Jude, works to raise funds to operate and maintain the hospital and its research efforts.

Research Leader

St. Jude is a unique institution: It is both a pediatric hospital dedicated to the care of children and a research institution focused on discoveries to advance understanding and treatment of catastrophic childhood diseases. The hospital fosters collaboration between laboratory scientists and clinical investigators – patients treated at St. Jude benefit not only from scientific advances but also from answers to clinical questions that help inform laboratory research. In addition to pioneering translational research, St. Jude is a leader in pediatric genome research. In 2010, St. Jude and Washington University School of Medicine in St. Louis launched the Pediatric Cancer Genome Project, the most ambitious effort yet to understand the origins of childhood cancer. Since then the normal and cancer genomes of more than 800 young patients have been sequenced, leading to deeper understanding of the genetic factors behind some of the toughest pediatric cancers. St. Jude is building on that foundation to develop a state-of-the-art clinical genomics program to better diagnose and treat children with cancer.

Global Collaborator

St. Jude freely shares scientific breakthroughs made in the hospital's laboratories and clinics so doctors and researchers worldwide can use that knowledge to save more children. Through its expanding global outreach program, the hospital also works to improve pediatric cancer survival rates worldwide by pioneering new treatment approaches and creating international pediatric cancer treatment networks.

Treatment Influencer

St. Jude is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children, reflecting excellence in patient care, research, education and community outreach. The pioneering work of St. Jude has helped to push the survival rate for the most common childhood cancer, acute lymphoblastic leukemia (ALL), from 4 percent when the hospital opened in 1962 to more than 94 percent today.

St. Jude is also a leader in helping survivors navigate life after cancer. Those efforts include St. Jude LIFE, an ongoing study that brings long-term childhood cancer survivors back to the hospital for regular health screenings throughout their lives. Thousands of participants have participated in the study. The findings help survivors learn how to better manage their health and provide researchers with insights for designing future therapies.